, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like
analysis for the three-month period ended September 30, 2019 To: Director and Manager of the Stock Exchange of Thailand Referring to the submission of reviewed financial statements for quarter 3/2019 of Wiik
No. INGRS059 14 September 2020 Subject : Management Discussion & Analysis (MD&A) for the consolidated financial statements of the 2nd quarter ended 31 July 2020 To : The President The Stock Exchange
No. CC20191103ELE November 12, 2019 Re: Clarification of the changes in operation performance for the third quarter and the nine- month period ended 30 September 2019 Attn: The President The Stock
Page 1 of 2 AC6305/006 May 14, 2020 Subject Clarification of the operating results for the quarter 1/2020 ended March 31, 2020 To Director/ Managing Director The Stock Exchange of Thailand According
recent development in this area is the SEC Board’s approval of amendments to the Stock Exchange of Thailand (SET) regulations to improve the screening process for companies applying for SET listing and to
Special Investigation (DSI) for manipulating prices of 12 securities during 2008-2010.With referral from the Stock Exchange of Thailand on irregular trading condition of 12 securities, the SEC probed into
Bangkok, April 21, 2014 ? The SEC jointly with the National Science and Technology Development Agency (NSTDA), the Stock Exchange of Thailand (SET), the Thai Business Incubators and Science Parks
Analysis | 2 Executive Summary In 3Q2018, domestic palm oil production has increased as in other countries, in addition, stock of Crude Palm Oil (CPO) both in Thailand and International market has remained
1 (Translation) AT JSP/61/02/02 February 6, 2018 Subject The disposal of investment of joint venture (Revise) To The President The Stock Exchange of Thailand The Board of Director’s Meeting No.1/2018